Connect with us

Business

Moderna, via Takeda, seeks authorization for COVID-19 vaccine in Japan – MarketWatch

Shares of Moderna Inc. undefined were down 0.9% in premarket trading on Friday after the company said it is pursuing approval for its COVID-19 vaccine in…

Published

on

Article feature image
ADVERTISEMENT

Shares of Moderna Inc.
MRNA,
-4.10%
were down 0.9% in premarket trading on Friday after the company said it is pursuing approval for its COVID-19 vaccine in Japan in partnership with Takeda Pharmaceutical Co.
4502,
-0.58%
.
Takeda submitted the new drug application and will be tasked with importing and distributing the vaccine from the Cambridge, Mass.-based company. Takeda is also conducting the Phase 1/2 trial of the vaccine in adults who are at least 20 years old there; enrollment ended…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Jobless Claims Fell to a New Pandemic Low Last Week – The Wall Street Journal
Article feature image
Retail sales explode in March as consumers use stimulus checks to spend heavily – CNBC
Article feature image
CDC expert panel punts on deciding fate of J&J COVID vaccine – Ars Technica